CARDIFF, Calif. (AP) — CARDIFF, Calif. (AP) — Viracta Therapeutics, Inc. (VIRX) on Thursday reported a loss of $13.7 million in its fourth quarter.
On a per-share basis, the Cardiff, California-based company said it had a loss of 35 cents.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.
Advertisement
For the year, the company reported a loss of $50.9 million, or $1.32 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VIRX at https://www.zacks.com/ap/VIRX